WST

WST

USD

West Pharmaceutical Services Inc. Common Stock

$286.940+8.560 (3.075%)

实时价格

Healthcare
Medical Instruments & Supplies
美国

价格图表

Loading Chart...

关键指标

市场指标
公司基本面
交易统计

市场指标

开盘价

$278.380

最高价

$287.875

最低价

$277.195

成交量

0.41M

公司基本面

市值

20.6B

所属行业

Medical Instruments & Supplies

国家/地区

United States

交易统计

平均成交量

0.64M

交易所

NYQ

货币

USD

52周价格范围

最低价 $187.43当前价 $286.940最高价 $348.9

相关新闻

Analyst Upgrades

TD Cowen Initiates Coverage On West Pharmaceutical Servs with Buy Rating, Announces Price Target of $350

TD Cowen analyst Brendan Smith initiates coverage on West Pharmaceutical Servs with a Buy rating and announces Price Target of $350.

查看更多
TD Cowen Initiates Coverage On West Pharmaceutical Servs with Buy Rating, Announces Price Target of $350
Analyst Upgrades

Barclays Maintains Equal-Weight on West Pharmaceutical Servs, Raises Price Target to $325

Barclays analyst Luke Sergott maintains West Pharmaceutical Servs with a Equal-Weight and raises the price target from $275 to $325.

查看更多
Barclays Maintains Equal-Weight on West Pharmaceutical Servs, Raises Price Target to $325
PR Newswire

West Synchrony™ Prefillable Syringe System Launches at CPHI: Redefining a system-level solution for drug delivery

West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the...

查看更多
West Synchrony™ Prefillable Syringe System Launches at CPHI: Redefining a system-level solution for drug delivery
Analyst Upgrades

UBS Maintains Buy on West Pharmaceutical Servs, Raises Price Target to $355

UBS analyst John Sourbeer maintains West Pharmaceutical Servs with a Buy and raises the price target from $320 to $355.

查看更多
UBS Maintains Buy on West Pharmaceutical Servs, Raises Price Target to $355
Analyst Upgrades

Keybanc Maintains Overweight on West Pharmaceutical Servs, Raises Price Target to $350

Keybanc analyst Paul Knight maintains West Pharmaceutical Servs with a Overweight and raises the price target from $325 to $350.

查看更多
Keybanc Maintains Overweight on West Pharmaceutical Servs, Raises Price Target to $350
PR Newswire

West to Participate in Upcoming Investor Conferences

West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it...

Analyst Upgrades

Evercore ISI Group Maintains Outperform on West Pharmaceutical Servs, Raises Price Target to $390

Evercore ISI Group analyst Daniel Markowitz maintains West Pharmaceutical Servs with a Outperform and raises the price target from $350 to $390.